Photo taken from Benedikt Westphalen/Twitter
Oct 24, 2023, 15:49
Benedikt Westphalen: First results of CUPISCO presented at ESMO23
Quoting Benedikt Westphalen, Medical Lead Precision Oncology, on X/Twitter:
“First results of CUPISCO presented at ESMO23.
Comprehensive genomic profiling, an MTB, and targeted treatments improve progression-free survival in patients with poor prognosis cancer of unknown primary over platinum CTX.
THIS IS BIG ”
Source: Benedikt Westphalen/Twitter
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Mar 22, 2025, 16:27
Mar 22, 2025, 14:55
Mar 22, 2025, 14:41
Mar 22, 2025, 14:28
Mar 22, 2025, 13:46
Mar 22, 2025, 13:29
Mar 22, 2025, 13:16
Mar 22, 2025, 12:47
Mar 22, 2025, 12:27
Mar 22, 2025, 12:06